Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1997-6-4
|
pubmed:abstractText |
Positron emission tomography and single-photon emission computer tomography receptor-binding ligands can be used to measure changes in neurotransmitter levels. In particular, amphetamine-induced dopamine release has been assessed with [11C]raclopride by paired bolus injections and with [123I]iodobenzamide by using a single bolus plus infusion (B/I) study. Here, we measured the change in [11C]raclopride-specific binding in rhesus monkeys after i.v. administration of 0.4 mg/kg amphetamine by using both the bolus and B/I paradigms. Paired bolus studies (control and postamphetamine) were analyzed using compartment modeling and graphical analysis with a new plasma metabolite model to measure the total distribution volume (VT). Specific binding, calculated with three measures linearly proportional to the binding potential, demonstrated a 22-42% reduction in the postamphetamine study. VT values from B/I studies were determined by the tissue-to-plasma ratio at equilibrium, in addition to the bolus methods. There was good agreement between the control VT values between bolus and B/I studies. The amphetamine-induced change in specific binding in B/I studies was 19 +/- 16%, measured directly from tissue radioactivity levels. This study demonstrates that stimulus-induced changes in specific binding can be measured with a single [11C]raclopride study using the B/I method.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amphetamine,
http://linkedlifedata.com/resource/pubmed/chemical/Carbon Radioisotopes,
http://linkedlifedata.com/resource/pubmed/chemical/Dopamine Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Raclopride,
http://linkedlifedata.com/resource/pubmed/chemical/Salicylamides
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0271-678X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
437-47
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9143226-Amphetamine,
pubmed-meshheading:9143226-Animals,
pubmed-meshheading:9143226-Basal Ganglia,
pubmed-meshheading:9143226-Carbon Radioisotopes,
pubmed-meshheading:9143226-Cerebellum,
pubmed-meshheading:9143226-Chromatography, High Pressure Liquid,
pubmed-meshheading:9143226-Dopamine,
pubmed-meshheading:9143226-Dopamine Antagonists,
pubmed-meshheading:9143226-Infusion Pumps,
pubmed-meshheading:9143226-Infusions, Intravenous,
pubmed-meshheading:9143226-Macaca mulatta,
pubmed-meshheading:9143226-Models, Biological,
pubmed-meshheading:9143226-Raclopride,
pubmed-meshheading:9143226-Salicylamides,
pubmed-meshheading:9143226-Tomography, Emission-Computed
|
pubmed:year |
1997
|
pubmed:articleTitle |
Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion.
|
pubmed:affiliation |
Positron Emission Tomography Department, National Institutes of Health, National Institutes of Mental Health, Bethesda, Maryland 20892-1180, USA.
|
pubmed:publicationType |
Journal Article
|